The global Food Allergy Market is on a significant growth trajectory, projected to expand from USD 44.1 billion in 2025 to USD 73.2 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.2%, according to recent market analysis. This surge underscores increasing prevalence of allergic conditions, heightened regulatory focus, and advancements in treatment modalities that are reshaping patient outcomes worldwide.
Rising Demand Fueled by Prevalence and Awareness
Food allergies have become a global public health challenge, with both pediatric and adult populations experiencing rising incidence rates. Severe allergic reactions, including anaphylaxis, are driving demand for accurate diagnostics and effective management solutions. Regulatory bodies in North America and Europe are strengthening allergen labeling laws, while consumer advocacy groups emphasize the importance of food safety and standardized treatment.
Notably, the peanut allergen segment is expected to account for 30.5% of the market in 2025, largely due to its disproportionate impact on anaphylaxis cases. This underscores the urgency of therapeutic innovation and continued research in desensitization therapies.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/food-allergy-market
Market Segmentation and Key Trends
The Food Allergy Market is segmented by Allergen Source (peanut, gluten, mustard, milk, egg, fish, others), Treatment (antihistamines, adrenaline, oral immunotherapy, others), End Use (hospitals, clinics, ambulatory surgery centers), and Region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa).
- By Treatment: Antihistamines remain the leading therapy, accounting for 35% of revenue in 2025, due to their accessibility and rapid relief from mild to moderate reactions. Oral immunotherapy (OIT), while still emerging, is projected to capture 22% of the market by 2035, with FDA approval of peanut OIT products paving the way for broader adoption.
- By End Use: Hospitals dominate with 42% share in 2025, leveraging their infrastructure for emergency intervention and specialized allergy care.
- By Region: North America leads with an estimated 43% share, fueled by high awareness, FDA-approved therapies, and robust healthcare infrastructure. Europe follows with 36% share, where regulatory standards and rising hospital admissions for severe allergies highlight unmet needs.
Competitor Benchmarks and Emerging Start-ups
Industry leaders such as Aimmune Therapeutics, Allergy Therapeutics, Astellas Pharma, Prota Therapeutics, Aravax, and Cambridge Allergy Ltd. are investing heavily in immunotherapy pipelines and novel biologics to capture growing demand.
Meanwhile, innovative start-ups are reshaping the competitive landscape:
- Ready, Set, Food! has attracted investors like Danone Manifesto Ventures and Mark Cuban, focusing on childhood allergy prevention through early introduction products.
- OITWorks leverages mobile health technology to help parents track and manage oral immunotherapy treatments.
- Foods You Can provides allergen-friendly product comparisons, underscoring the digital shift in consumer-driven healthcare.
This dual dynamic of established pharma players and agile start-ups is driving faster innovation cycles, while collaborations such as FARE’s partnership with Vionic aim to expand patient education and research funding.
Key Growth Drivers
Several macro factors are propelling market growth:
- Rising comorbidity with asthma – Food allergy and asthma often coexist, intensifying severity risks and driving demand for integrated care solutions.
- Increased healthcare spending and infrastructure upgrades – Governments are funding allergy research and improving diagnostic capabilities globally.
- Consumer-driven dietary shifts – Demand for gluten-free, dairy-free, and allergen-free food products continues to rise, influencing both the food and healthcare sectors.
- Advancements in immunotherapy – Promising research in peptide immunotherapy, DNA vaccination, and anti-IgE therapies is setting the stage for long-term tolerance induction.
Challenges and Barriers
Despite strong momentum, the market faces hurdles. Diagnostic inconsistencies, high costs of testing, and underdiagnosis in low-resource settings remain key challenges. Younger patients in particular face difficulties due to invasive testing procedures. Industry organizations such as the European Federation of Allergy and Airways Diseases Patients Associations (EFA) are working to bridge awareness gaps through global campaigns.
Get Sample Report: – https://www.futuremarketinsights.com/reports/sample/rep-gb-16170
Future Outlook
Between 2025 and 2035, the Food Allergy Market is expected to expand steadily, with innovation in diagnostics and immunotherapy driving the next phase of growth. Increasing R&D investments, coupled with expanding regulatory support, will unlock opportunities for both established pharmaceutical firms and disruptive start-ups.
The sector is also witnessing a cultural shift toward proactive allergy management, integrating allergy screening into primary care and enhancing patient quality of life. With millions worldwide at risk of life-threatening reactions, the market is poised for accelerated innovation and adoption of next-generation therapies.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
